Compare Stocks

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

Datalex plc develops and sells various distribution and retailing software products and solutions to the airline industry in Ireland, the Americas, the Asia Pacific, the United Kingdom, and rest of European countries. The company operates in two segments, E-Business and TPF Consulting. It offers Datalex Direct, a customer-centric digital commerce product for travel retailing through airlines' direct channels; Datalex Merchandiser that enables airlines to deploy intelligent merchandising strategies across channels and touchpoints, generates ancillary revenue, and optimizes traveler engagement at various point in their journey; Datalex NDC, which offers order management for indirect channel using NDC; and Datalex Dynamic, which creates and optimizes capabilities by allowing airlines to build customer centric, contextualized, and personalized offers for air and non-air products. The company also provides Datalex China Shopping and Pricing Engine, an air shopping and pricing solution for Chinese airlines; and Datalex Pricing AI, a real-time pricing product. In addition, it delivers professional and hosting services; and offers online payment processing connectivity services. Further, the company provides IT consultancy services to airlines; and develops and sells computer software. The company was founded in 1985 and is headquartered in Dublin, Ireland.

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Pharos Energy plc, an independent energy company, engages in the exploration, development, and production of oil and gas properties in Vietnam, Egypt, and China. The company was formerly known as SOCO International plc and changed its name to Pharos Energy plc in October 2019. Pharos Energy plc was incorporated in 1997 and is headquartered in London, the United Kingdom.

Wentworth Resources Limited, an independent energy company, engages in the exploration, development, production, and transportation of natural gas and other hydrocarbons in Tanzania and Mozambique. It primarily holds 31.94% interest in the Mnazi Bay concession covering an area of approximately 756 square kilometers in south-eastern Tanzania; and 85% participating interest in the Rovuma Onshore Block in northern Mozambique. The company was formerly known as Artumas Group Inc. and changed its name to Wentworth Resources Limited in September 2010. Wentworth Resources Limited is based in Calgary, Canada.